1. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry. Issue 5 (May 2023) Authors: Zhao, Nan; Chen, Chen; Guo, Yuhong; Liu, Tieju; Che, Na; Zhang, Danfang; Liang, Xiaohui; Zhang, Yanhui; Zhao, Xiulan Journal: Digestive and liver disease Issue: Volume 55:Issue 5(2023) Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗